Staphylococcus aureus (MRSA) Reduction

Authors
Travis R. Farley, Study Director
Facility
Microbac Laboratories, Inc.; North Carolina
Download
Full Report

Objective

To evaluate the efficacy of the Protect 900 on reducing methicillin-resistant Staphylococcus aureus (MRSA).

Methodology

The challenge bacteria were aerosolized using a six-jet collision nebulizer under high pressure air and introduced into the chamber with the Protect 900.

Summary of Results

The Protect 900 reduced 99.99% of Staphylococcus aureus bacteria over the course of four hours.

Protect 900 achieved 99.99% reduction of MRSA

Contact

USA Headquarters
3540 Toringdon Way, Suite 200 Charlotte, NC  28277
1 866 508 1118
info@wellairsolutions.com

Ireland Headquarters
DCU Innovation Campus
Old Finglas Road
Glasnevin, Dublin D11 KXN4
+353 1 907 2750
info@wellairsolutions.com

Contact WellAir

Social

Partners